Potential for Pharmacy–Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases-Reference-Cited by-同舟云学术

Potential for Pharmacy–Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases

Published:2017-11 Issue:6 Volume:23 Page:593-600
ISSN:1078-4659
Container-title:Journal of Public Health Management and Practice
language:en
Short-container-title:

Author:

Gubbins Paul O.,Klepser Michael E.,Adams Alex J.,Jacobs David M.,Percival Kelly M.,Tallman Gregory B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference33 articles.

1. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States;Weber;Exp Rev Mol Diagn.,2016

2. Public health perceptions of community pharmacy partnership opportunities;Roberts;J Public Health Manag Pract.,2015

3. Physician-pharmacist collaborative practice agreements: a strategy to improve adherence to evidence-based guidelines;Adams;Evid Based Med Public Health.,2015

4. Leveraging partnerships among community pharmacists, pharmacies, and health departments to improve pandemic influenza response;Rubin;Biosecur Bioterror.,2014

5. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy;Gubbins;J Am Pharm Assoc.,2014

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing Implementation of point-of-care testing for acute respiratory infectious diseases in community pharmacies: A scoping review using the Consolidated Framework for Implementation research;Research in Social and Administrative Pharmacy;2024-06

2. Opportunities for pharmacist prescriptive authority of buprenorphine following passage of the Mainstreaming Addiction Treatment (MAT) Act;Journal of the American Pharmacists Association;2023-09

3. Revisiting the continuum of pharmacist prescriptive authority;Journal of the American Pharmacists Association;2023-09

4. Pharmacist Prescribing Models for HIV Pre-exposure and Post-exposure Prophylaxis;Annals of Pharmacotherapy;2023-07-21

5. Hepatitis C screening in a community pharmacy setting: Patient perspective;Journal of the American Pharmacists Association;2023-07